Colonization with Clostridium difficile in Children with Cancer
- PMID: 24427503
- PMCID: PMC3883379
Colonization with Clostridium difficile in Children with Cancer
Abstract
Objective: Clostridium difficile is a gram-positive, anaerobic, spore-forming bacillus. Usually it does not cause disease unless a patient who is colonized with toxin-producing strains has been treated with antibiotics, particularly those that change the anaerobic flora of the large intestine.
Methods: We investigated in a prospective study intestinal colonization of C. difficile and its toxins in children with malignancy that used different antibiotics and cytotoxic drugs.
Findings: One hundred fifty-two patients were included in this prospective study. Stool samples were obtained within the first 48 hours after admission and cultured for C. difficile; cytopathic effect of C. difficile was detected on HELA cells, also ELISA test was performed for detection of toxins A and B. 25% of patients had positive culture for C. difficile; 36/38 (92%) revealed positive cytopathic effect on HELA cells. No significant relation was found between age, gender, history of antibiotic consumption and C. difficile positive culture and cytopathic effect on HELA cells. The only relation was seen between cotrimoxazol usage and cytopathic effect on HELA cells (P=0.03).
Conclusion: Although the rate of C. difficile colonization (25.6%) and toxigenic strains (23.7%) in admitted children in hematologic ward is high, the rate of ELISA positive test for toxin A+B was not correspond with culture and cytopatic effect on HELA cell. With respect to sensitivity and specificity of ELISA test, possibility for existence of toxin C with cytopathic effect is high in this type of patients.
Keywords: Cancer; Clostridium Difficile; Colonization; Cytopathic Effect.
Figures
Similar articles
-
Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients.BMC Geriatr. 2016 Nov 15;16(1):185. doi: 10.1186/s12877-016-0358-3. BMC Geriatr. 2016. PMID: 27846818 Free PMC article.
-
[Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].Mikrobiyol Bul. 2011 Jan;45(1):1-10. Mikrobiyol Bul. 2011. PMID: 21341153 Turkish.
-
Theodore E. Woodward Award. How bacterial enterotoxins work: insights from in vivo studies.Trans Am Clin Climatol Assoc. 2002;113:167-80; discussion 180-1. Trans Am Clin Climatol Assoc. 2002. PMID: 12053708 Free PMC article. Review.
-
Clostridium Difficile Colonization in Hematopoietic Stem Cell Transplant Recipients: A Prospective Study of the Epidemiology and Outcomes Involving Toxigenic and Nontoxigenic Strains.Biol Blood Marrow Transplant. 2016 Jan;22(1):157-63. doi: 10.1016/j.bbmt.2015.07.020. Epub 2015 Jul 26. Biol Blood Marrow Transplant. 2016. PMID: 26211988 Clinical Trial.
-
Rapid detection of Clostridium difficile toxins and laboratory diagnosis of Clostridium difficile infections.Infection. 2017 Jun;45(3):255-262. doi: 10.1007/s15010-016-0940-9. Epub 2016 Sep 6. Infection. 2017. PMID: 27601055 Review.
Cited by
-
Pathogens causing diarrhoea among Bangladeshi children with malignancy: Results from two pilot studies.World J Clin Cases. 2020 Jan 26;8(2):276-283. doi: 10.12998/wjcc.v8.i2.276. World J Clin Cases. 2020. PMID: 32047775 Free PMC article.
-
Epidemiology, Diagnosis, and Treatment of Clostridioides difficile Infection in Immunocompromised Children.J Pediatric Infect Dis Soc. 2021 Nov 17;10(Supplement_3):S46-S51. doi: 10.1093/jpids/piab078. J Pediatric Infect Dis Soc. 2021. PMID: 34791397 Free PMC article.
-
The rate and importance of Clostridium difficile in colorectal cancer patients.Gastroenterol Hepatol Bed Bench. 2019 Fall;12(4):358-363. Gastroenterol Hepatol Bed Bench. 2019. PMID: 31749925 Free PMC article.
-
Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis.Am J Gastroenterol. 2015 Mar;110(3):381-90; quiz 391. doi: 10.1038/ajg.2015.22. Epub 2015 Mar 3. Am J Gastroenterol. 2015. PMID: 25732416
-
Evaluation of the prevalence of Aeromonas spp., Campylobacter spp., and Clostridioides difficile in immunocompromised children with diarrhea.BMC Infect Dis. 2024 May 22;24(1):512. doi: 10.1186/s12879-024-09372-3. BMC Infect Dis. 2024. PMID: 38778271 Free PMC article.
References
-
- Johnson S, Clabots CR, Linn FV, et al. Nosocomial Clostridium difficile colonization and disease. Lancet. 1990;336(8707):97–100. - PubMed
-
- Clabots CR, Johnson S, Olson MM, et al. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis. 1992;166(3):561–7. - PubMed
-
- Anand A, Glatt AE. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis. 1993;17(1):109–13. - PubMed
-
- Colarian J. Clostridium difficile colitis following antiviral therapy in the acquired immunodeficiency syndrome. Am J Med. 1988;84(6):1081. - PubMed
-
- Chiesa C, Gianfrilli P, Occhionero M, et al. Clostridium difficile isolation in leukemic children on maintenance cancer chemotherapy. Clin Pediatr (Phila) 1985;24(5):252–5. - PubMed
LinkOut - more resources
Full Text Sources